IMMUNOHISTOCHEMISTRY, MELAN-A

The IHC – Melan-A test is an immunohistochemistry-based diagnostic assay used to detect Melan-A protein expression in tissue samples. Melan-A, also known as MART-1 (Melanoma Antigen Recognized by T-cells 1), is a protein commonly found in melanocytes, the pigment-producing cells of the skin.

This test is widely used in pathology to identify and confirm melanocytic tumors, especially malignant melanoma, one of the most aggressive forms of skin cancer. Melan-A is considered a highly sensitive marker for melanocytic differentiation and is frequently used in combination with other melanoma markers such as HMB-45, S100, and SOX10.

Benefits of the Test

• Helps diagnose malignant melanoma
• Identifies melanocytic tumor origin
• Assists in differentiating melanoma from other cancers
• Improves accuracy in skin tumor classification
• Supports treatment planning and prognosis evaluation

Why Doctors Recommend This Test

Doctors recommend the IHC Melan-A test when there is suspicion of melanoma or melanocytic lesions. It is commonly used in:

• Evaluation of suspicious pigmented skin lesions
• Diagnosis of malignant melanoma
• Differentiation of metastatic melanoma from non-melanocytic tumors
• Classification of melanocytic neoplasms
• Oncology biopsy interpretation

Melan-A is especially valuable because it highlights melanocytic cells clearly, helping pathologists determine whether a tumor is derived from melanocytes.

Preparation Before Test

No special preparation is required for this test. Important points include:

• The test is performed on a skin biopsy or surgical tissue sample
• No fasting or medication restrictions are necessary
• Previous pathology reports and clinical findings may assist interpretation

Normal Reporting Time

The typical turnaround time is 3 to 5 working days, depending on tissue processing and laboratory workflow.

Who Should Take This Test

• Patients with suspicious skin lesions
• Individuals with suspected melanoma
• Cases requiring confirmation of melanocytic tumors
• Patients undergoing skin biopsy evaluation
• Oncology patients with metastatic tumor investigation

The IHC Melan-A test is an important diagnostic tool in dermatopathology and oncology. It helps identify melanocytic tumors accurately, ensuring early diagnosis and effective treatment planning for melanoma and related conditions.